Advanced search
Publication Cover
Expert Review of Medical Devices Volume 20, 2023 - Issue 11
Submit an article Journal homepage
100
Views
0
CrossRef citations to date
0
Altmetric
Device Profile

Device evaluation: eCoin #x2013; implantable tibial nerve stimulator for overactive bladder

Morgan J Bressingtona Urology Registrar, Tauranga Hospital, New ZealandView further author information
,
David Scholtza Urology Registrar, Tauranga Hospital, New ZealandView further author information
,
Ali Hooshiarya Urology Registrar, Tauranga Hospital, New ZealandView further author information
,
Wikus Vermeulenb Urologist, Tauranga Hospital, Tauranga, New Zealand;d Honorary Senior Lecturer, University of Auckland, Auckland, New ZealandView further author information
,
Timothy Burnsa Urology Registrar, Tauranga Hospital, New ZealandView further author information
,
Flavio Ordonesb Urologist, Tauranga Hospital, Tauranga, New Zealand;d Honorary Senior Lecturer, University of Auckland, Auckland, New ZealandCorrespondence[email protected]
View further author information
&
Peter Gillingb Urologist, Tauranga Hospital, Tauranga, New Zealand;c Faculty of Medical and Health Sciences, University of Auckland, Auckland, New ZealandView further author information
 show all
Pages 899-904 | Received 17 Nov 2022, Accepted 30 Aug 2023, Published online: 21 Sep 2023

References

  • Haylen BT, De Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. Urology. 2010 Jan; 29(1): 4-20.
  • White WM, Mobley JD 3rd, Doggweiler R, et al. Incidence and predictors of complications with sacral neuromodulation. Urology. 2009 Apr 1;73(4):731–735.
  • Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta‐analysis. Neurourol Urodyn. 2012 Nov;31(8):1206–1216.
  • Peters KM, Carrico DJ, Wooldridge LS, et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013 Jun 1;189(6):2194–2201.
  • Kaaki B, English S, Gilling P, et al. Six-month outcomes of reimplantation of a coin-sized tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence. Female Pelvic Med Reconstr Surg. 2022 May;28(5):287–292. doi: 10.1097/SPV.0000000000001105
  • Martinson M, MacDiarmid S, Black E. Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation. Journal Of Urology. 2013 Jan 1;189(1):210–216. doi: 10.1016/j.juro.2012.08.085
  • MacDiarmid S, Staskin DR, Lucente V, et al. Feasibility of a fully implanted, nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence. Urol J. 2019 May;201(5):967–972. doi: 10.1016/j.juro.2018.10.017
  • Rogers A, Bragg S, Ferrante K, et al. Pivotal study of leadless tibial nerve stimulation with ecoin® for urgency urinary incontinence: an open-label, single arm trial. J Urol. 2021 Aug;206(2):399–408. doi: 10.1097/JU.0000000000001733
  • Gilling P, Meffan P, Kaaki B, et al. Twelve-month durability of a fully-implanted, nickel-sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence: a single-arm, prospective study. Urology. 2021 Nov 1;157:71–78. doi: 10.1016/j.urology.2021.04.039
  • Vollstedt A, Gilleran J. Update on implantable PTNS devices. Curr Urol Rep. 2020 Jul;21:1–5. doi: 10.1007/s11934-020-00980-5
  • Khaneshi M, Rahnama’i MS, Ebrahimi SH. MP32-17 EFFECTIVITY of a NOVEL IMPLANTABLE DEVICE (STIMROUTER) for the TREATMENT of OVERACTIVE BLADDER SYNDROME: 30 MONTHS RESULTS of a MULTI-CENTRE STUDY. J Urol. 2022 May;207(Supplement 5):e538. doi: 10.1097/JU.0000000000002581.17
  • Al-Danakh A, Safi M, Alradhi M, et al. Posterior tibial nerve stimulation for overactive bladder: mechanism, classification, and management outlines. Parkinson’s Disease. 2022 Mar 16;2022:1–12. doi: 10.1155/2022/2700227
  • Peters KM, MacDiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. Journal Of Urology. 2009 Sep;182(3):1055–1061. doi: 10.1016/j.juro.2009.05.045
  • Nitti VW, Dmochowski R, Herschorn S, et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun;189(6):2186–2193. doi: 10.1016/j.juro.2012.12.022
  • Jairam R, Drossaerts J, Marcelissen T, et al. Predictive factors in sacral neuromodulation: a systematic review. Urol Int. 2022 May 31;106(4):323–343. doi: 10.1159/000513937

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.